Spirometry is a cornerstone test for diagnosing, monitoring and managing respiratory diseases. Because spirometry provides valuable insights into overall lung function, it can be used to diagnose common lung ailments, including asthma and chronic obstructive pulmonary disease (COPD), among others. Technological advancements in spirometry have resulted in highly reliable data output. Combining technological data with correct medical interpretation and spirometry offers a foundation for accurate clinical decisions. In this blog, we’ll walk through the essential spirometry metrics, including Forced Vital Capacity (FVC), Forced Expiratory Volume in 1 Second (FEV1) and the FEV1/FVC ratio, and how they are used to assess lung health.
Understanding Spirometry Values
Interpreting spirometry results hinges on comparing the patient’s values to established reference ranges. In the United States, these reference ranges are adjusted for age, gender, height, and ethnicity to reflect our diverse population norms.
A spirometry test requires patients to take deep breaths and exhale into a spirometer, which will measure and record a series of parameters related to lung function and performance. Three key metrics are obtained during this test:
- FVC (Forced Vital Capacity): The total air volume a patient can forcefully exhale after taking a deep breath.
- FEV1 (Force Expiratory Volume in 1 Second): The air volume expelled during the first second of the FVC maneuver provides insight into airway function.
- FEV1/FVC Ratio: Expressed as a percentage, this ratio compares the air exhaled in the first second to the total exhalation, highlighting potential airway obstruction.
Indicators of Healthy Lung Function
In an individual with healthy lung function, these values should fall within the predicted normal range, typically above 80% of the expected values for FEV1 and FVC. Variations from these norms can indicate respiratory pathology.
How to Read Abnormal Spirometry Results
When spirometry values deviate from normal ranges, trained healthcare professionals can use this information to identify potential respiratory issues. These are primarily diagnosed through three pattern categories:
- Obstructive patterns: Obstructive lung diseases, such as COPD and asthma, are characterized by a reduced FEV1/FVC ratio, often falling below 70%. This ratio suggests airway narrowing, which means that patients will struggle to exhale most of their air in the first second of forced expiration. A low FEV1 typically accompanies this pattern, but some conditions, such as early-stage asthma, may present near-normal FEV1 levels despite the significant obstruction.
- Restrictive patterns: Restrictive lung diseases like pulmonary fibrosis lead to decreased lung volumes (low FVC) with a preserved or even increased FEV1/FVC ratio. This pattern indicates that the patient has difficulty fully expanding the lungs during inhalation. Additional tests, such as lung volume measurement or total lung capacity, may be required to confirm that restriction occurs.
- Mixed patterns: Some patients present with concurrent obstructive and restrictive traits. Mixed patterns can occur in certain conditions. For example, a patient with combined COPD and interstitial lung disease will have airway obstruction and reduced lung expansion simultaneously. This flow-volume curve becomes an essential diagnostic tool in cases like these, as it visually represents abnormalities in airflow and volume throughout the respiratory cycle.
Reversibility Testing
Bronchodilator testing can further differentiate between reversible and fixed air obstructions. Spirometry is performed in patients with suspected asthma before and after administering a bronchodilator. A significant improvement in FEV1 (12% or more) or FVC (a minimum of 200 mL in volume) indicates reversible airway obstruction and points to asthma as a likely diagnosis.
Clinical Applications for Spirometry
Spirometry is vital for diagnosing and managing several common respiratory conditions, including:
- Asthma: A reversible obstructive pattern that commonly improves with bronchodilator administration.
- COPD: An irreversible obstructive pattern with little to no reversibility after bronchodilator use.
- Restrictive Lung Disease: This is marked by reduced lung volumes (low FVC) and preserved or elevated FEV1/FVC ratios, necessitating further testing to quantify lung volumes.
Regular spirometry use helps track disease progression and treatment response. For example, declining FEV1 over time in COPD patients suggests worsening airflow limitation, which could indicate treatment adjustments are needed.
Spirometry Limitations
While spirometry is a powerful and accurate diagnostic tool, it does have some limitations. It may not detect early-stage disease or subtle lung function abnormalities. When spirometry results are inconclusive, more detailed lung assessments may be required, including full lung pulmonary function testing (PFT), diffusion capacity testing or imaging studies (chest X-rays or CT scans). This additional testing will provide further diagnostic clarity when needed.
MIR Spirometry can help connect you with the right types of testing devices to meet your patient’s needs. See our professional product portfolio here.
Follow-Up and Frequency of Spirometry Testing
The frequency of spirometry testing depends on the individual patient’s condition. Asthma patients who can control their symptoms will likely not need frequent testing, but patients with poorly controlled asthma may require more frequent testing to guide treatment plan adjustments. Stable COPD patients may require annual testing to monitor disease progression or more frequent testing should symptoms advance.
Over time, repeated spirometry tests can become a valuable resource for healthcare providers in tailoring effective treatment strategies designed to optimize patient outcomes.
Interested in discovering your potential ROI from Pulmonary Function Testing?
Use our new Reimbursement Calculator to estimate your practice's earning potential based on weekly patient numbers. You’ll learn how incorporating pulmonary function testing can benefit your patients and your bottom line.
At MIR, we offer cutting-edge spirometers and oximeters designed to meet the precise needs of healthcare professionals and patients alike. Whether for clinical use or home monitoring, our products deliver reliable, accurate respiratory measurements easily and efficiently.
Recognized globally for innovation and quality, MIR is proud to be certified to the highest standards worldwide. Contact MIR USA to learn how our spirometers can support better lung health for your patients while enhancing your practice's diagnostic capabilities.
